4imprint Group PLC
22 December 2004
4imprint Group PLC
22 December 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) NAME OF COMPANY
4IMPRINT GROUP PLC
2) NAME OF DIRECTORS
GILLIAN DAVIES AND ANDREW JAMES SCULL
3) Please state whether notification indicates that it is in respect
of holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of a non-beneficial interest
IN RESPECT OF THE 4IMPRINT GROUP PLC EMPLOYEE SHARE TRUST OF WHICH GILLIAN
DAVIES AND ANDREW JAMES SCULL ARE POTENTIAL BENEFICIARIES
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
-
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
-
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
PURCHASE OF ORDINARY SHARES BY ABACUS TRUST COMPANY LIMITED ACTING IN ITS
CAPACITY AS TRUSTEE TO THE 4IMPRINT GROUP PLC EMPLOYEE SHARE TRUST(POTENTIAL
BENEFICIARY)
7) Number of shares/amount of
stock acquired
140,000
8) Percentage of issued Class
0.48%
9) Number of shares/amount
of stock disposed
-
10) Percentage of issued Class
-
11) Class of security
ORDINARY 38 6/13P
12) Price per share
176P
13) Date of transaction
20 December 2004
14) Date company informed
20 December 2004
15) Total holding following this notification
440,000
16) Total percentage holding of issued class following this notification
1.52%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
20 December 2004
18) Period during which or date on which exercisable
DATE ON WHICH PERFORMANCE TARGETS ARE REACHED, BUT, IN THE CASE OF GILLIAN
DAVIES AND ANDREW SCULL NOT EARLIER THAN 6 DECEMBER 2007. IN THE CASE OF
KENNETH MINTON, DATE ON WHICH PERFORMANCE TARGETS ARE REACHED BUT NOT EARLIER
THAN 8 JULY 2005 (IN RESPECT OF ONE THIRD), 8 JULY 2006 (IN RESPECT OF ONE
THIRD)AND 8 JULY 2007 (IN RESPECT OF ONE THIRD).
19) Total amount paid (if any) for grant of the option
NIL
20) Description of shares or debentures involved: class, number.
ORDINARY SHARES
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
PERFORMANCE TARGETS SET AT £2, £2.50 AND £3.
22) Total number of shares or debentures over which options held
following this notification
540,000
23) Any additional information
OPTIONS OVER 300,000 SHARES HAVE BEEN GRANTED TO KENNETH MINTON
OPTIONS OVER 120,000 SHARES EACH HAVE BEEN GRANTED TO GILLIAN DAVIES AND
ANDREW JAMES SCULL
24) Name of contact and telephone number for queries
TIM HALLAM
(0161) 272 4000
25) Name and signature of authorised company official responsible for
making this notification
ANDREW SCULL
Date of Notification 22.12.04
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.